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ABSTRACT

Polycyclic aromatic hydrocarbons (PAHs) are hydrophobic organic compounds
consisting of two or more fused benzene rings. PAHs derive from many different sources
including petroleum refining, wood treatment, and coal coking industries. Because of
their structural stability and water insolubility, PAHs are extremely resistant to
degradation. These compounds are also believed to have mutagenic, carcinogenic, and
teratogenic effects. Therefore, there are currently 16 PAH compounds on the EPA’s list
of priority pollutants.
Many species of bacteria have the ability to breakdown these persistent pollutants.
However, bioremediation strategies using these organisms have many unresolved issues.
While laboratory experiments can easily demonstrate the ability of these organisms to
breakdown pollutants, environmental factors may reduce degradation abilities in situ.
Within the prokaryotes, members of the genus Sphingomonas have demonstrated a
greater ability to breakdown PAHs. Spingomonas paucimobilis EPA505, for example,
was shown to degrade a wide range of PAHs including the high molecular weight PAH
fluoranthene, which it could also use as a sole carbon source. Because of its potential as
a bioremediation tool, it is important to study the molecular basis of PAH catabolism in
EPA505.
A genomic library of EPA505 was constructed and probed for genes involved in PAH
degradation. Complete gene sequences were obtained for four subunits which are
involved in the first step of the PAH catabolism. This step is catalyzed by a dioxygenase
enzyme and yields a dihydrodiol intermediate. Two of the gene sequences encode an
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alpha and beta subunit of the dioxygenase. The third gene encodes a ferredoxin subunit
and the fourth gene codes for a ferredoxin reductase subunit.
The four genes were cloned for expression. Expression host cells were induced to test
the activity of the four recombinant proteins on various PAHs. When cells expressing all
four subunits were incubated with naphthalene and phenanthrene, the corresponding
dihydrodiol product was detected using GC-MS. No dihydrodiol product was detected
when fluoranthene was tested. In addition, no dihydrodiol products were detected for any
substrate when cells lacking the two ferredoxin subunits were tested.
This study identified and showed functional analysis of one enzyme, a PAH degrading
dioxygenase in the PAH catabolic pathway of Sphingomonas paucimobilis EPA505.
There is still much to learn in order to fully appreciate and take advantage of this
organism as an efficient tool for bioremediation.
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LITERATURE REVIEW

1.1 Polycyclic Aromatic Hydrocarbons
Polycyclic aromatic hydrocarbons (PAHs) are hydrophobic organic compounds
consisting of two or more fused benzene rings. Ring arrangement can be linear, angular
or clustered. These compounds are generally classified into two categories based on size:
1) low molecular weight (LMW) PAHs which contain two or three benzene rings and 2)
high molecular weight (HMW) PAHs which contain four or more rings. For example,
naphthalene, phenanthrene and anthracene would be considered LMW PAHs whereas,
fluoranthene, pyrene and chrysene would be considered HMW PAHs.
PAHs derive from many different sources including petroleum refining, wood
treatment, and coal coking industries. Other sources of PAHs can include gasoline and
diesel fuel combustion, and tobacco smoke (1). PAHs are ubiquitous pollutants which
can contaminate water, vegetation and food. These compounds and their derivatives can
be found in the air, soil, surface water, groundwater and runoff. Pollutant concentration
varies widely throughout the environment ranging from 1µg/kg to over 300g/kg. Factors
that determine the amount of contamination include distance from the source, level of
industrial development, and mode of transport for the pollutant (39).
The aromatic structures of PAHs make them chemically stable molecules. They are
water insoluble and form hydrophobic interactions with soil particles. Because of their
structural stability and water insolubility, PAHs are extremely resistant to degradation.
They sorb strongly to soil particles and become inaccessible for degradation. Larger
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PAH molecules are more hydrophobic, and more resistant to degradation and therefore
have a higher prevalence in the environment. For example, phenanthrene, a three-ringed
PAH, may have a half life of 16 to 126 days. The half life of the five ringed PAH
benzo[a]pyrene (Ba P), however, can range from 229 to 1,400 days (3).

1.2 Health Risks
Health risks associated with PAHs have been well documented. These compounds are
thought to have mutagenic, carcinogenic, and teratogenic effects. Because of these
concerns, there are currently 16 PAH compounds on the EPA’s list of priority pollutants
(Table 1.1) (4).
Kusk et al. (5) found a significant decrease in the photosynthetic activity of green
algae that were exposed to PAHs. PAHs have also caused digestive cell death in mussels
(6), decreased reproductive rates in rainbow trout (7), and increased mortality rates in
crustaceans (8).
With regard to mammalian studies, mice that were fed high levels of one PAH during
pregnancy had difficulty reproducing as did their offspring. The offspring also had higher
rates of birth defects and lower body weights (4). PAHs have caused lung cancer in
laboratory animals that were exposed to contaminated air, stomach cancer when fed
contaminated food, and skin cancer when PAHs were applied directly to the skin (4).
PAHs can contaminate vegetation through the soil and through runoff. They can then
be taken up by mammals through the digestive tract when contaminated food is ingested
(9). PAHs can even be transferred to humans through the consumption of seafood that
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was caught in contaminated waters (10). Because of the chemical nature of these
compounds, they might associate with lipid components in biological tissues and interact
with DNA to cause mutations in both prokaryotic and eukaryotic cells (11).
An example of the toxic effects of PAHs can be shown with naphthalene.
Naphthalene binds to molecules in the liver, kidney and lung tissues and is known to
inhibit mitochondrial respiration (12). Phenanthrene, is known to be a photosensitizer of
human skin and is also mutagenic to bacteria (13). These are examples of some of the
effects of LMW PAHs and it is thought that larger PAHs pose more serious health
hazards (14).
It is true that these pollutants do undergo degradation in the environment over time.
The rate at which this occurs, however, is much slower than the rate at which new PAHs
are released into the environment. The Exxon Valdez oil spill of 1989, for instance,
affected the fate of many organisms. The pink salmon community in particular showed a
reduction in egg survival rates for many years. Contaminants were also transferred by
tidal cycling and hydraulic gradients to reach developing embryos. In recent years,
significant changes in the spawning habitats were seen, which indicated the salmon were
recovering from the spill (15). Although this is good news, it is evidence of the
persistence of PAHs in our environment. After more than a decade, the effects of this
major environmental incident have still not completely disappeared.
Old PAH contamination is not the only problem to solve. There are much more recent
examples of large scale PAH pollution. The September 11th attacks gave rise to the
release of 100-1000 tons of PAHs throughout lower Manhattan and beyond. The highest
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PAH concentrations were found at the sites closest to the fires. Those involved in the
cleanup have been affected greatly. There have been numerous reports of PAH related
respiratory illness including, persistent coughs, bronchitis, and new cases of asthma. It is
said that these people and others who were exposed have a real risk for lung cancer in the
future (16).

1.3 Bioremediation
Many bioremediation strategies have been developed to clean up PAH contamination.
Some species of bacteria, fungi and even plants have the ability to degrade these
pollutants.
Although it was believed that eukaryotic organisms could not cleave the fused rings of
PAHs, Hammel et al. showed the mineralization of phenanthrene by the lignolytic fungus
Phanerochaete chrysosporium (17). The white rot fungus Pleurotus ostreatus also
demonstrated the ability to metabolize phenanthrene (18).
Phytoremediation, another bioremediation strategy, involves the use of plants to clean
up contaminated soil. Levels of acenaphthalene, anthracene, phenanthrene, naphthalene,
and fluoranthene all decreased significantly in soils planted with green ash and hybrid
poplar trees compared to unplanted soils. There was also an increase in the population of
microbial degraders in the planted soil versus the unplanted soil (3). The authors
suggested the trees increased the rates of PAH degradation through microbial activity in
the rhizosphere.
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Although bacteria in the rhizosphere might assist plants in effectively degrading
PAHs, they can certainly clean up contaminated soils independently. Bacteria are well
known for their adaptation abilities and diverse characteristics. Many species of bacteria
are known to degrade PAHs. Heitkamp and Cerniglia found Mycobacterium PYR-1 can
degrade fluoranthene, naphthalene and phenanthrene but cannot use these compounds as
a sole carbon source (19). Analysis of contaminated soil samples led to the identification
of three strains of PAH degrading Burkholderia cepacia. All three isolates degraded
fluorene, phenanthrene, pyrene, fluoranthene, benz[a,h]anthracene,
dibenz[a,h]anthracene and benzo[a]pyrene (20). Krivobok et al. (2) showed
14

C-pyrene mineralization by Mycobacterium sp. strain 6PYI. An increase in catabolic

activity and the expression of two ring-cleavage proteins was observed in cells grown on
pyrene compared to those grown on acetate (2). Alcaligenes denitrificans strain WW1
was isolated by Weissenfels et al. (21) and was found to degrade fluoranthene at a rate of
0.3 mg/ml a day. Other PAHs, including pyrene and benz[a]anthracene were also
degraded by strain WW1 via cometabolic processes (21). Cycloclasticus, an organism
isolated from marine sediments was able to partially degrade 1 ppm pyrene and 1 ppm
fluoranthene when 10 ppm phenanthrene was provided in culture (10). While these
findings are important, few organisms have been found which can degrade compounds
with more than three fused benzene rings and additionally can use these compounds as
sole sources of carbon and energy.
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1.4 Problems with Bioremediation
Although bacteria can breakdown PAHs, this does not mean the PAH pollution
problem is solved. In fact, bioremediation through the use of PAH degrading bacteria
like EPA505 has great potential for PAH cleanup, but there are many unresolved
problems. While laboratory experiments can easily demonstrate the ability of these
organisms to breakdown pollutants, environmental factors may reduce degradation
abilities in situ. Some of the factors that affect the efficiency of in situ degradation
include targeting microbes to the pollutants, soil moisture, oxygen, temperature, pH,
microbial predation, availability of nutrients, and the production of inhibiting
metabolites.
One major problem with bioremediation has to do with the chemical nature of PAHs.
Because of hydrophobic interactions, PAHs are sometimes inaccessible to microbial
degraders in the environment. Whereas smaller organic compounds might be degraded,
large PAH molecules are tightly bound to soil particles and as a result accumulate (22).
Another problem with bioremediation of PAHs is partial degradation. Some
organisms can begin to breakdown the initial compound, but environmental factors may
inhibit the complete breakdown process. Partial degradation of PAHs can pose a bigger
threat as metabolites may be more toxic than parent compounds. Bouchez et al. (4)
studied the co-metabolic activity of six bacterial strains grown on several different PAHs.
Synergistic activity as well as inhibition was noted. Furthermore, the production of water
soluble metabolites was found consistently throughout the experiment (4).
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If inhibition leads to the accumulation of water soluble intermediate metabolites, the
result might be contaminated water sources.
Some PAHs are partially broken down through abiotic processes such as
photooxidation. While this may seem helpful, it can actually lead to a bigger problem.
Phenanthrene for example, can be converted by sunlight to the more polar product
9,10-phenanthrenequinone (PheQ). PheQ can react with biomolecules and, therefore, is
much more toxic than its parent compound phenanthrene. The increased toxicity of PheQ
compared to phenanthrene was demonstrated in bacteria (23) and plants (24). PheQ was
also shown to inhibit naphthalene degradation by Burkholderia. There was a 20%
degradation of naphthalene in the presence of PheQ as compared to a 75% degradation
with no PheQ. The same study showed that a Sphingomonas species could degrade
PheQ, but only in the presence of phenanthrene (25).
Bioremediation problems also exist with S. paucimobilis EPA505. For example,
fluoranthene degradation by EPA505 is sometimes inhibited by creosote constitutents.
An experiment was done to determine which creosote components were actually
inhibiting the breakdown process. Creosote compounds were categorized into three
groups: acidic (phenolics), basic (N-heterocyclics), and neutral (PAHs). Results
indicated the inhibitory effects were mostly a result of the basic components in creosote
(26). Although the authors found the chemical source of the problem, they did not know
why there was inhibition. More information on gene expression and regulation might
lead to solutions to these types of problems.
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1.5 Sphingomonads
The Sphingomonads refer to organisms belonging to one of four genera including:
Sphingomonas, Sphingobium, Sphingopyxis, and Novosphingobium. Members of this
group are widespread in the environment. They have been isolated from both aqueous
and terrestrial habitats as well as clinical specimens and other sources (27).
First described by Yabuuchi et al. (1990), the Sphingomonads are Gram-negative,
chemoheterotrophic, non-spore forming rod-shaped bacteria. These organisms typically
produce yellow pigmented colonies. Some cells may contain a single polar flagellum,
but others may be non-motile. One distinctive characteristic of these organisms is that
they have glycosphingolipids in their cell envelopes instead of the more typical
lipopolysaccharides (27). Although there is no evidence to date, it has been suggested
that these glycosphingolipids may play a role in the successful uptake of PAHs for
biodegradation (28).
Representatives of the genus Sphingomonas seem to have a wider range of substrates
than other organisms. For example, Novosphingobium aromaticivorans strain F199 can
grown on toluene, xylene, p-cresol, biphenyl, naphthalene, dibenzothiophene, fluorene,
salicylate and benzoate (29,30). S. yanoikuyae B1 can grown on 1,2,3- trimethylbenzene,
toluene, p-xylene, biphenyl, naphthalene, phenanthrene and anthracene (31).
In addition to a wider range of substrates, certain Sphingomonad species can utilize
PAHs as a sole carbon and energy source. For example, whereas many other organisms
have been shown to degrade two and three-ringed PAHs such as naphthalene,
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phenanthrene and anthracene, the Sphingomonads can also break down HMW PAHs with
four and five-rings such as fluoranthene, pyrene, and benzopyrene (32).
Sphingomonas paucimobilis EPA505 was isolated from a seven member community
from a creosote waste site (33). It was one of the first organisms reported to degrade and
use a HMW PAH (fluoranthene) as a sole carbon and energy source (34). Fluoranthene
utilization was shown by an increase in cell biomass, disappearance of the HMW PAH,
and by the production of metabolites. Additionally, EPA505 cells grown on fluoranthene
could degrade other compounds such as benzo[b]fluorene, benz[a]anthracene, chrysene,
and pyrene (34). Ye et al. (1) studied the degradation activity of fluoranthene grown
EPA505 cells on other HMW PAHs. After 16 hours of incubation with 10 ppm of the
specific compound, S. paucimobilis degraded 80% of pyrene, 72.9% benz[a]anthracene,
31.5% chrysene, 33.3% benzo[a]pyrene, 12.5% benzo[b]fluoranthene, and 7.8%
dibenz[a,h]anthracene. They also found an increase in degradation activity with
increased cell density. In addition, cells that were incubated with [7-14C] labeled
benzo[a]pyrene, and [5, 6, 11, 12-14C] labeled chrysene for 48 hours, degraded 28% of
the former and 42% of the latter to 14CO2 (1).

1.6 PAH Catabolic Pathway
Naphthalene is commonly used as a model compound for PAH degradation studies.
Although there are some exceptions, the primary pathway for naphthalene degradation is
divided into an upper and lower catabolic pathway. For the upper catabolic pathway,
(Fig. 1.1) the first step occurs when a ring hydroxylating dioxygenase introduces two
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molecules of oxygen to initiate cleavage of the aromatic ring and form naphthalene cisdihydrodiol. The dihydrodiol product is then dehydrogenated to 1,2dihydroxynaphthalene by a cis-naphthalene dihydrodiol dehydrogenase. The next step
involves another dioxygenase, namely 1,2-dihydroxynaphthalene dioxygenase which
yields the product 2-hydroxy-2H-chromene-2-carboxylic acid. The next two reactions
are catalyzed by a carboxylate isomerase and a hydratase-aldolase to give
salicylaldehyde. This product is converted to salicylate by a dehydrogenase. In the lower
catabolic pathway (Fig. 1.2) salicylate is further degraded to TCA cycle intermediates
either through the catechol or gentisate pathways. Similar catabolic steps are involved
for the degradation of phenanthrene, anthracene and other aromatic hydrocarbons.

1.7 Genetics of PAH Degradation in Sphingomonads
The genetics of PAH degradation have been studied in some Sphingomonas species.
The genes involved in aromatic hydrocarbon degradation in this group seem to be highly
conserved and have been shown to be different from those described in other genera (28).
The sequence of a 40kb region from Sphingobium yanoikuyae B1 revealed over 35
genes on 6 different operons involved in aromatic hydrocarbon degradation. While at
least five sets of ring-hydroxylating dioxygenases were found, only one ferredoxin
reductase (bphA4) and ferredoxin (bphA3) was found among all the genes identified.
However, these two proteins were found to be associated with multiple dioxygenase
components (35). Analysis of the genes in B1 also revealed that the first three enzymes
in the pathway work on a broad range of substrates and can metabolize naphthalene,
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phenanthrene and biphenyl. The nahD gene of B1 encoding the 2-hydroxychromene-2carboxylate isomerase, however, was only involved in the degradation of naphthalene
(35). Sphingobium yanoikuyae B1 is unusual in that the genes required for the
degradation of a compound are not arranged on the same operon (28).
The complete sequence of a 184-kb catabolic plasmid, pNL1, from Novosphingobium
aromaticivorans strain F199 has been ascertained (36). Romine et al. found 79 genes on
the plasmid that are associated with breakdown or transport of PAHs. Of the genes
identified, those that are involved in PAH degradation are in the same order and
transcriptional direction as the same genes on strain B1. In addition to the five
dioxygenase components found in B1, a sixth terminal oxygenase component was
identified on pNL1 (36). Genes xylB, nahF, bphD, bphE and bphF were also identified
on pNL1, but functional analysis has not yet been done (28).
In Sphingobium strain P1, transposon mutagenesis interrupted the ferredoxin subunit
(ahdA4) of a dioxygenase, impairing the ability of the organism to degrade phenanthrene.
As with strain B1, five sets of terminal oxygenase components were also identified, but
only one ferredoxin and one ferredoxin reductase were identified. Additionally, two
meta-cleavage enzymes bphC and xylE were identified which had 100% identity with
those genes of strain B1 (37).
Recently, the sequence of an aromatic ring-hydroxylating dioxygenases of
Sphingomonas strain CHY-1 were identified and tested for enzymatic activity.
Demaneche et al. found the sequence of two genes coding for the alpha and beta subunits
of a terminal oxygenase, phnA1a and phnA2a (38). The product of these two genes was
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collectively called PhnI. Genes encoding a ferredoxin component (phnA3) and
ferredoxin reductase component (phnA4) were also identified on separate loci. All four
genes were highly similar to genes found in strain F199. When incubated with several
different substrates, recombinant PhnI converted PAHs to the respective dihydrodiol
products. Furthermore, enzyme activity increased greatly with the co-expression of the
ferredoxin and ferredoxin reductase subunits (38).
Limited work has been done on the genetics of PAH degradation in Sphingomonas
paucimobilis EPA505. Tn5 mutants were used to delineate the catabolic pathway of
EPA505. Story et al. also found that while a common hydroxylase is involved in the
pathways for the different substrates studied, EPA505 possesses two distinct hydratasealdolase genes. One is involved in the degradation of naphthalene, phenanthrene and
anthracene, and the other involved in fluoranthene degradation (40). It was suggested
that the genes involved in PAH degradation in strain EPA505 are located on several
different operons as seen in the other members of this group.
Partial gene sequences were obtained for some of the genes involved in the PAH
catabolic pathway of EPA505 when the regions flanking Tn5 inserts were sequenced.
Because of its wide range of substrates and ability to grow on some compounds as a sole
source of carbon, S. paucimobilis EPA505 has great potential for bioremediation. It is
therefore necessary to study the genetic basis of degradation in this organism in more
detail.
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1.8 Ring-Cleaving Dioxygenases
As mentioned earlier, there are several enzymes involved in the PAH upper catabolic
pathway (Fig 1.1). The first enzyme in the pathway is a ring-hydroxylating dioxygenase.
This enzyme initiates the breakdown of the PAH substrate by introducing two oxygen
molecules into the aromatic ring structure to form a dihydrodiol product.
These enzymes are all soluble, multi-component systems that are usually made up of
two or three separate proteins including: a ferredoxin, a ferredoxin reductase and an ironsulfur protein. The iron-sulfur protein is made up of an alpha and beta subunit and is the
catalytic oxygenase component (41). The proteins are arranged in a short electrontransport chain where electrons are moved to the catalytic terminal oxygenase (Fig. 1.3)
(28).
For naphthalene dioxygenase, the reductase component is the first component in the
electron-transport chain. Transport is initiated by a single two-electron transfer from
NAD(P)H to FAD in the ferredoxin reductase which gives the reduced form of FAD.
The reduced FAD then provides electrons to the ferredoxin. These electrons are then
transferred to the iron-sulfur protein or terminal oxygenase which uses the electrons in its
active site to introduce an oxygen molecule into the aromatic ring (28). The terminal
oxygenase component of the chain consists of three alpha and three beta subunits. These
subunits come together to form a mushroom like shape with the three alpha subunits
forming the cap and the three beta subunits forming the stem (52).
The substrate specificity of naphthalene dioxygenase has also been investigated.
Parales et al. showed that the Asp-205 residue in the catalytic domain of naphthalene
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dioxygenase is necessary for activity. When site-directed mutagenesis was employed to
change this residue to either, alanine, glutamate, asparagine or glutamine, mutant proteins
were not able to transform naphthalene to the dihydrodiol product. In addition, oxygen
uptake by the mutant protein was decrease when compared to the wild-type (42). This
study confirmed that aspartate was responsible for the successful transfer of electrons to
the active site.
Although S. paucimobilis EPA505 has the ability to break down a wide range of
substrates and exhibits greater PAH degrading capabilities when compared to other
organisms, there is limited information on the catabolic enzymes in this organism. The
purpose of this work was to identify complete gene sequences encoding PAH degrading
dioxygenases in EPA505, compare the sequences identified to those in related organisms,
and carry out functional analysis of the enzymes. Fundamental knowledge of PAHcatabolic genes and gene products in this strain may ultimately give way to more efficient
bioremediation strategies.
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Table 1.1 US EPA’s 16 priority-pollutant PAHs and selected physical–chemical properties.
Molecular weight
g/mole

Solubility
mg/L

Naphthalene

128.17

31

Anthracene

178.23

0.045

Phenanthrene

178.23

1.1

Pyrene

202.26

0.132

Acenaphthene

154.21

3.8

Acenaphthylene

152.20

16.1

Flourene

166.22

1.9

Fluoranthene

202.26

0.26

Chrysene

228.29

0.0015

Benzo (a) pyrene

252.32

0.0038

Benz (a) anthracene

228.29

0.011

Benzo (k) fluoranthene

252.32

0.0008

Indeno (1,2,3- cd) pyrene

276.34

0.062

Benzo (b) fluoranthene

252.32

0.0015

Dibenzo (a,h) anthracene

278.35

0.0005

Benzo (g,h,i) perylene

276.34

0.00026

PAH

Chemical Structure
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Figure 1.1 Upper catabolic pathway of naphthalene degradation (60). Enzymes: (A) naphthalene
dioxygenase, (B) cis-naphthalene dihydrodiol dehydrogenase, (C) 1,2-dihydroxynaphthalene dioxygenase,
(D) 2-hydroxychromene-2-carboxylate isomerase, (E) trans-o-hydroxybenzylidenepyruvate hydratasealdolase, (F) salicylaldehyde dehydrogenase.
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Figure 1.2 Naphthalene lower catabolic pathway. Salicylic acid created in the upper pathway is further
metabolized either through the catechol or gentisic acid pathways to TCA cycle intermediates (60).
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Figure 1.3 Initial step of naphthalene oxidation catalyzed by a multi-component dioxygenase (28). The
ferredoxin reductase accepts electrons and transfers them to a ferredoxin which transfers again to the terminal
oxygenase components. The reduced terminal oxyenase then catalyzes the oxidation of the aromatic
compound to produce a dihydrodiol (41).

MATERIALS AND METHODS

2.1 Reagents
All PAHs, solvents, antibiotics, and derivatizing agents were purchased from SigmaAldrich (St. Louis, MO). Primers and oligonucleotides were purchased from Integrated
DNA Technologies (San Diego, CA). Unless otherwise stated, restriction endonucleases
and other DNA modification enzymes were purchased from Promega (Madison, WI).

2.2 Bacterial Strains, Plasmids and Growth Conditions
Sphingomonas paucimobilis EPA505 was isolated from a creosote waste site (34).
One colony of S. paucimobilis EPA505 was inoculated into 10 ml of Luria Bertani (LB)
broth and incubated at 37°C with shaking. When the culture reached late log phase,
chloramphenicol was added to a final concentration of 200 µg/ml and the culture was
incubated further at 37°C with shaking for one hour. Chloramphenicol was added to
ensure the genomic DNA collected was from cells in late log phase. After treatment with
chloramphenicol, cells were harvested and prepared for library construction.
E. coli strains and plasmids used are listed in Table 2.1. All organisms for
recombinant DNA experiments were grown in LB media supplemented with the
appropriate antibiotics.
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2.3 BAC Library Construction
Genomic library construction was carried out at the Clemson University Genomics
Institute (CUGI). To construct a BAC (Bacterial Artificial Chromosome) library, high
molecular weight (HMW) bacterial DNA was first embedded into agarose plugs. S.
paucimobilis EPA505 cells were harvested from a late exponential phase culture and
washed once with 2 ml of NaCl/Tris(pH7.2)/EDTA (200mM NaCl, 10 mM Tris-Cl,
100mM EDTA)and then resuspended in 0.5 ml of the same buffer. The cell suspension
was then placed in a 37°C water bath for 5 minutes. A solution of 2% (w/v) SeaPlaque
GTG agarose (FMC BioProducts, Rockland, ME) in water was prepared and equilibrated
to 40°C in a water bath. One volume of the agarose solution was mixed with the cell
suspension, mixed and the solution was poured into plug molds. After setting, the plugs
were removed and placed in a 15 ml screwcap tube and 2-3 volumes of bacterial cell lysis
solution for HMW DNA (10 mM Tris-Cl, 50 mM NaCl, 100 mM EDTA, 0.2% sodium
deoxycholate, 0.5% N-lauroylsarcosine, 1mg/ml lysozyme) was added and the mixture
incubated at 37°C for 2-16 hours. All BAC library construction procedures after
preparation of genomic DNA were carried out as previously described (53).

2.4 Overgo Probing of High-Density BAC Membranes
Following BAC library construction, high density membranes were made in order to
probe the library for genes of interest. Overgo probes were designed from partial PAH
gene sequences previously obtained from EPA505 (40). To carry out hybridization, 50
ml of warm hybridization solution (1% BSA, 1 mM EDTA, 7% SDS, 0.5 M sodium
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phosphate) was added to a hybridization bottle. Membranes were pre-moistened with
warmed 2X SSC and then rolled into a hybridization bottle for a 4-hour prehybridization.
After prehybridization, about 10 ml of hybridization buffer was removed from the bottle.
After denaturing the labeled overgos at 90°C for 10 minutes, the probes were added to the
10ml of buffer and mixed. The 10 ml was then added back to the bottle with the
membrane. Probes were allowed to hybridize overnight in a hybridization oven set at
60°C with rotation.
After hybridization, the buffer was removed and the membrane was washed three
times. The membrane was washed first with 1x SSC, 0.1% SDS, second with 1.5x SSC,
0.1% SDS and once more with 0.75X SSC, 0.1% SDS. All three washes were carried out
at 58°C for 30 minutes. For autoradiography, the filter was sealed in a plastic zip top bag
and exposed to XAR5 film at 70°C.

2.5 Southern Analysis
BAC clones containing genes of interest were digested and analyzed by Southern
blot/hybridization. BAC DNA was purified by maxi-prep (43). Purified DNA was then
digested at 37°C overnight with HindIII and BamHI (Promega, Madison, WI) and size
fractionated in a 0.8% (w/v) SeaKem LE agarose gel (BioWhittaker Molecular
Applications, Rockland, ME) using 1× TAE (40 mM Tris-acetate, 1 mM EDTA, pH 8.0)
as a running buffer.
After separation was completed, the gel was depurinated by incubation in 0.125 N
HCl followed by a 30 minute incubation in denaturing buffer (1.5 M NaCl, 0.5 M
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NaOH), and finally a 30 minute incubation in neutralization buffer (1.5 M NaCl, 0.5 M
Tris pH 7.5). DNA was transferred to Hybond-XL membrane (Amersham Pharmacia
Biotech, Little Chalfort, Buckinghamshire, England) by capillary blot using 10× SSC (pH
7) as a transfer buffer. Following transfer, DNA was fixed to the membrane by baking at
80°C for 2 hours.
The membrane was prehybridized at 65°C with a 0.5 M sodium phosphate, 7%
sodium dodecylsulfate (SDS) hybridization buffer for a minimum of 30 minutes.
Radioactively labeled and denatured DNA probe was added directly to the
prehybridization solution, and the membrane was hybridized with the probe overnight at
65°C. The hybridized membrane was washed at 65°C twice with 2× SSC (pH 7.0), 1%
(w/v) SDS for 30 minutes, and twice with 1× SSC, 0.1% (w/v) SDS for 30 minutes. The
membrane was then exposed to autoradiographic film (Kodak X-Omat Blue XB-1,
Perkin-Elmer Life Sciences, Inc., Boston, MA) overnight.

2.6 Shotgun Library Construction
To construct a shotgun library, BAC DNA was purified by maxi-prep (43) and
subjected to random fragmentation by hydroshearing (Gene Machines, San Carlo, CA).
Fragments between 3-5 kb were selected by agarose gel electrophoresis, subjected to
end-repair/phosphorylation using the End-it end repair kit (Epicentre, Madison, WI), and
was then cloned into the high copy plasmid pBlueskriptIIKSII+. Plasmids were then
electroporated into E. coli DH10B cells. Transformants were selected on LB plates
containing carbenicillin, X-Gal and IPTG. White recombinant colonies were picked
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robotically using the Genetix Q-bot (Genetix, San Jose, CA) and stored as individual
clones in Genetix 96-well microtiter plates as glycerol stocks at -80°C.

2.7 Primer Design
Primer3 software (47) was used to design primers (http://frodo.wi.mit.edu/primer3).
Genes phnA1a, phnA2a, and phnA3 were found on contigs assembled from high
throughput sequencing. To clone these genes, primers were designed to include the
appropriate restriction sites before and after the start and stop codons of the gene
sequences. To locate phnA4, a series of primers were designed based on conserved
regions of this gene. Several consecutive rounds of PCR using primer walking and
04N04 BAC DNA as a template were carried out to eventually obtain the entire phnA4
gene.

2.8 Sequencing and Analysis
Sequencing was carried out at CUGI. Shotgun clones were sequenced using the
universal priming sites on the vector. The data was collected on an ABI 3730xl DNA
Analyzer (Applied Biosystems, Carlsbad, CA). For sequencing, 10 ng of DNA for every
1 kb of sequence and 0.3 µl of 2 µM primer were used.
DNA sequence and assembly was carried out using Phred, Phrap, and Consed (44).
Sequence data was also assembled using Sequencher DNA assembly software (Gene
Codes Corp, Ann Arbor, MI) and the free BioEdit sequence alignment editor program
(mbio.ncsu.edu/BioEdit/bioedit.html). The GenBank tool BLAST at the NCBI server
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was used to perform similarity searches for genes and proteins (48). GeneMark free gene
prediction software (49) was used to search for open reading frames
(exon.biology.gatech.edu). The ProtParam tool at the Expasy Proteomics Server
(expasy.org/sprot) was used to determine the size, amino acid sequence and other
properties of recombinant proteins. Phylogenetic trees were constructed using MEGA
software version 4.0 (50) and multiple sequence alignments were carried out with
ClustalW (51).

2.9 Cloning for Protein Expression
For protein expression, genes were cloned into the petDUET-1 and pACYCduet-1
vectors (Novagen, Madison, WI). Genes of interest were amplified using 04NO4 BAC
DNA as a template and KOD Hot Start Polymerase according to the manufacturer’s
cycling recommendations (Novagen, Madison, WI). All PCR and gel purification steps
were carried out using the Wizard SV Gel and PCR Clean-Up System (Promega
Madison, WI).
Compatible Duet expression vectors were kindly provided by Dr. Michael Sehorn of
Clemson University, Department of Genetics and Biochemistry (Fig. 2.1 and 2.2). Both
Duet vectors were provided on agar plates within cultures of E.coli DH5α. Cells were
grown overnight in LB broth supplemented with either ampicilin for pETDuet-1
(50µg/ml) or chloramphenicol for pACYCDuet-1 (34µg/ml). Plasmid extraction was
carried out with Qiagen tip-100 and the midi-prep protocol (Qiagen, Valencia, CA).
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PCR products were then digested as follows: phnA1a and phnA3 PCR products were
digested with BamHI and HindIII and were subsequently cloned into the BamHI and
HindIII sites of petDUET-1 and pACYCduet-1, respectively. The phnA2a and phnA4
PCR products were digested with BglII and KpnI and cloned into the second multiple
cloning sites of petDUET-1 and pACYCduet-1, respectively. Digested vector was
dephosphorylated with Thermosensitive Alkaline Phosphatase (Promega, Madison, WI).
Ligation was carried out with the Ligafast Rapid DNA ligation system (Promega,
Madison, WI). Genes phnA1a and phnA2a encoding two oxygenase components were
cloned into pETDuet-1 to give pD12. Genes phnA3 and phnA4 encoding the ferredoxin
and ferredoxin reductase components were cloned into pACYCDuet-1 to yield the
plasmid pACD34.
Transformation was carried out according to the manufacturer’s instructions into
either E. coli Novablue host cells (Novagen, Madison, WI) for maintenance stocks, or
into E.coli BL21(DE3) cells for expression of target proteins. Successful transformation
and cloning were confirmed with colony PCR using vector specific primers.

2.10 Protein Expression/ SDS-PAGE
To express target proteins, BL21(DE3) cells were transformed with either pD12 or
pACD34 or co-transformed with both plasmids to express all four proteins. Controls
were also analyzed in which BL21(DE3) cells were transformed with the original vectors
pETDuet-1 and/or pACYCDuet-1 containing no insert. LB broth plus the appropriate
antibiotic was inoculated with one colony from the BL21(DE3) transformation and
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incubated overnight at 37°C with shaking. The overnight culture was used to inoculate a
secondary culture which was incubated at 37°C with shaking until the OD600 > 0.5. At
this point the culture was split in half and IPTG was added to one half at a final
concentration of 1 mM. The other half was not induced for comparison. The induced
and uninduced cultures were returned to a 37°C incubator with shaking for up to 8 hours
to analyze protein expression.
For SDS-PAGE analysis, cells were harvested and resuspended in phosphate buffered
saline and 2x SDS loading dye (1:1). The suspension was then boiled for 5 minutes and
centrifuged for 1 minute. Samples were then loaded onto tris-glycine precast gels
(Biorad, Hercules, CA) with Smart Protein Middle-Range Standard protein marker
(Genscript, Piscataway, NJ), and run at 120V until the dye front reached the bottom of
the gel. Gels were visualized with Commassie blue staining (43).

2.11 Assay for Recombinant Protein Activity
BL21(DE3)(pD12) expressing the two oxygenase components and
BL21(DE3)(pD12)(pACD34) expressing two oxygenase and two ferredoxin components
were tested for enzyme activity. BL21(DE3)(pETDUET-1) and BL21(DE3)(pETDuet1(pACYCDuet-1) harboring the plasmids without inserts were used as controls. Cells
were grown in LB broth with appropriate antibiotics to an OD600 > 0.5.
IPTG was then added to a final concentration of 1mM and the culture was incubated at
25°C overnight with shaking. Cells were harvested and resuspended in M9 minimal
medium plus 0.2% glucose at half the original volume so as to double the density of cells
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in suspension. In addition, 100 µg of either: naphthalene, phenanthrene or fluoranthene
dissolved in acetone was added to the cells. The culture was again incubated at 25°C
with shaking overnight. After exposure to the PAHs, cells were harvested and the
supernatant collected. The supernatant was extracted twice with ethyl acetate (1:1) and
dried over sodium sulfate. Extracts were evaporated using a rotary evaporator and the
residue was resuspended in 500 µl acetonitrile. Derivatization was carried out by
combining 100 µl of the final acetonitrile suspension with 50 µl BSTFA:TMS (99:1) and
incubated at 65°C for one hour to yield trimethylsilylated products. Samples were then
analyzed by GC-MS. All experiments were done in triplicate. PAH standards dissolved
in acetone were run for all substrates tested.

2.12 GC-MS analysis
Gas chromatography-mass spectrometry (GC-MS) was performed on an Agilent 7890
GC and an Agilent 5975 mass spectrometer with triple axis detector (Agilent, Santa
Clara, CA ). A J&W DB-5ms capillary column (30m by 0.25mm, 0.25µm film
thickness) was used for separation of metabolites. GC-MS analyses were performed as
follows: the initial oven temperature was set at 80°C and held for two minutes, the
temperature was then increased at a rate of 8°C per minute until 300°C where it was held
for 5 minutes. Electron ionization was achieved at 70eV electron energy and 150°C ion
source temperature. Sample injection volumes were 2 µl splitless. Samples were run in
scanning mode and the total run time was 34.5 minutes. Products were identified by
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comparing the data collected to published mass spectra of specific dihydrodiol
intermediates.
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Table 2.1 List of bacterial strains and plasmids used in this study.
Bacterial strain or plasmid
Strains
Sphingomonas paucimobilis EPA505
Escherichia coli DH10B
Escherichia coli Novablue
Escherichia coli BL21(DE3)

Plasmids
pCUGIBAC1
pBlueskriptIIKSII+
pETDuet-1
pACYCDuet-1
pD12
pACD3
pACD34

Relevance/Properties

Source/Reference

PAH degrading strain
genomic library host
maintenance host for cloned genes
expression host

Mueller et al., 1990
CUGI
Novagen
Novagen

BAC library vector, Camr
shotgun library vector, Ampr
protein expression vector, Ampr
protein expression vector, Camr
pETDuet-1 with phnA1a, phnA2a
pACYCDuet-1 with phnA3
pACYCDuet-1 with phnA3, phnA4

CUGI
CUGI
Novagen
Novagen
This study
This study
This study
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Figure 2.1 Vector map of pETDuet-1 plasmid used to clone phnA1a and phnA2a. Image
retrieved from www.merck-chemicals.com/life-science-research, September 10th, 2010.
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Figure 2.2 Vector map of the pACYCDuet-1 plasmid used to clone phnA3 and phnA4.
Image retrieved from www.merck-chemicals.com/life-science-research, September 10th,
2010.
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RESULTS

3.1 BAC Library/Overgo Probing of High Density Filters
A BAC library of Sphingomonas paucimobilis EPA505 was constructed at the
Clemson University Genomics Institute. Hybridization was carried out using
oligonucleotide probes designed from partial sequences obtained in previous experiments
(40). Following hybridization with the probe designed from a partial dioxygenase,
numerous positive spots were identified (Fig. 3.1). A few positive clones were randomly
picked from the library for further analysis.

Figure 3.1 Overgo probing of high density BAC filters. Dark dots indicate positive hybridization to
dioxygenase probe. Dot pattern indicates the location of the clone in the library.

32

3.2 Southern Analysis of BACs
DNA from the selected clones was extracted (Fig. 3.2) and subjected to restriction
digestion with BamHI and HindIII (Fig. 3.3). Southern blot analysis revealed potential
dioxygenase genes in some of the BAC clones. Because of the strong signal, BAC clone
#04NO4 was chosen to make a shotgun library (Fig. 3.5). After this selection process, a
shotgun library was constructed for high-throughput sequencing.

Figure 3.2 Agarose gel electrophoresis of DNA purified from selected BAC clones.

Figure 3.3 Agarose gel electrophoresis of digested BAC clones. After the marker in the first lane, every
two lanes represent one BAC clone digested with BamH1 in the first and HindIII in the second lane.
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04N04

Figure 3.4 Southern analysis of digested BAC clones. Membrane was probed with overgos designed from
partial dioxygenase gene sequences. Based on the strong signal, BAC #04N04 was chosen for shotgun
cloning.

3.3 Sequencing Analysis
A shotgun library was constructed from one BAC clone which revealed dioxygenase
genes following Southern analysis. After construction, the shotgun clones were subjected
to high throughput sequencing using universal priming sites on the cloning vector. After
all sequence data was collected, a total of 15 contigs were assembled. The results of
BLAST similarity searches for contigs which revealed putative genes are listed in Table
3.1. Several different dioxygenases were identified. However, only three putative genes
were selected for further analysis.
The first two genes were located on the same contig and showed 99% similarity to the
phnA1a and phnA2a genes of Sphingomonas CHY-1 (Fig. 3.5). These two genes encode
the alpha and beta subunits of an oxygenase. This contig also contained the aryl alcohol
dehydrogenase phnB. A third gene was found on another contig and was 99% similar to
the bphA3 of Sphingomonas CHY-1. This gene encodes a ferredoxin and will be referred
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to as phnA3. The phnA3 gene was found on a contig containing other dioxygenase genes
which were not selected for further analysis (Fig. 3.6 and Table 3.1).

Figure 3.5 Schematic diagram of the contig containing phnA1a and phnA2a. The two oxygenase
components are adjacent to one another and are followed by the aryl alcohol dehydrogenase gene, phnB.

xylX

bphC

bphA3

ahdA2c

ahdA1c

(phnA3)
Figure 3.6 Schematic diagram of the contig containing phnA3. The gene encoding the ferredoxin
component is preceded by two dioxygenase genes xylX and bph and is followed by genes encoding the
small (ahdA2c) and large (ahdA1c) subunits of an oxygenase.

According to the literature (38), a fourth gene encoding a ferredoxin reductase subunit
is necessary to complete the electron transport chain of the ring-hydroxylating
dioxygenase enzyme. However, this gene was not identified in the sequencing results of
the shotgun library. In order to find this gene, multiple rounds of PCR and sequencing
were carried out using primers designed from conserved regions of bacterial ferredoxin
reductase genes and using 04N04 BAC DNA as a template. After primer walking the
complete sequence of a fourth subunit was positively identified as it was found to be
100% similar to the ahdA4 gene of Sphingomonas sp. P2, which encodes a ferredoxin
reductase. The ferredoxin reductase subunit of EPA505 found here will be referred to as
phnA4. These four genes, i.e. phnA1a, phnA2a, phnA3 and phnA4 encode protein
products which are components that make up a complete ring-cleaving dioxygenase
enzyme shown to degrade both high and low molecular weight PAHs (38).
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The ProtParam tool at the Expasy Proteomics server was used to determine the
protein product size for each gene of interest. The gene encoding the alpha oxygenase
component, phnA1a, is 1365bp long and was predicted to encode a protein consisting of
454 amino acids with a molecular weight of approximately 50 kD in size. PhnA1a
contains more negatively charged residues than positively charged residues and is
considered a stable protein with an instability index of 28.12. The gene encoding the beta
subunit, phnA2a, is 525bp long. The protein product for this gene was predicted to be
174 amino acids long and approximately 21 kD in size. The amino acid composition for
PhnA2a shows this protein as having more negatively charged residues. It also estimates
an instability index of 47.35, classifying this protein as unstable. With regard to phnA3, a
327bp gene, the protein product was estimated to be 11.5 kD and 108 amino acids in
length. The amino acid composition shows more negative than positive residues and an
instability index of 41.16, classifying this protein as unstable. Lastly, the 1227bp gene
phnA4 encoding the ferredoxin reductase subunit, was estimated to be 408 amino acids in
length and 44 kD in size. The protein product for this gene was estimated to have more
negatively charged residues and an instability index of 31.05 making this protein stable.
Phylogenetic analysis revealed that the PhnA1a and PhnA2a subunits of EPA505 are
most closely related to the alpha and beta terminal oxygenase components of
Sphingomonas CHY-1 as was consistent with the BLAST results (Fig 3.18 and 3.19).
Other closely related terminal oxygenase components include the PhnA1f and PhnA2f of
Sphingomonas sp. LH128, the ArhA1 and ArhA2 subunits of Sphingomonas sp. A4, and
the BphA1f and BphA2f subunits of Sphingomonas yanoikuyae B1 (54-56).
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A multiple sequence alignment was done to compare the amino acid sequences of the
alpha and beta subunits of EPA505 to those of related organisms. When the beta subunit
PhnA2a was compared to the small subunit of the terminal oxygenase in six other
organisms, the alignment revealed that some but not most amino acids were conserved
(Fig. 3.21). When a multiple sequence alignment was done for PhnA1a, however, many
residues were conserved among the sequences compared (Fig. 3.20). Conserved residues
of significance include the six histidines and two cysteines which are thought to play a
role in the [2Fe-S] cluster of the alpha subunit (41) and the Asp205 which is believed to
connect the active site iron center of one alpha subunit to another (57, 58).

3.4 Cloning and protein expression
After the complete sequences of these four genes were identified, each gene was
amplified separately to include appropriate restriction sites for cloning. Genes phnA1a
and phnA2a encoding the oxygenase components were cloned into pETDueT-1 to give
pD12. Genes phnA3 and phnA4 encoding the ferredoxin components were cloned into
pACYCDuet-1 to yield the plasmid pACD34. In addition to these plasmids, expression
host cells were also transformed with the original vectors containing no insert to yield
BL21(DE3)(pETDuet-1) and BL21(DE3)(pETDuet-1)(pACYCDuet-1). These
transformants were used as controls.
BL21(DE3) cells harboring either or both pD12 and pACD34 were grown and
induced for expression. When BL21(DE3)(pD12) expressing only the two oxygenase
components was induced and the cell lysate was analyzed by SDS-PAGE, a 53 kD band
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and a 21 kD band was seen in the induced culture as compared to the uninduced cells.
These two bands represent the recombinant phnA1a and phnA2a gene products,
respectively (Fig3.7). Following induction of BL21(DE3)(pD12)(pACD34) expected to
express all four subunits, SDS-PAGE analysis revealed two prominent bands at the
expected sizes of the phnA1a and phnA2a products (Fig3.8). However, no representative
bands were seen for the ferredoxin or ferredoxin reductase components.

2h

1

2

4h

3

4

6h

5

6

8h

7

8

9

100 kD
75 kD
PhnA1a
50 kD
32 kD
25 kD
PhnA2a
15 kD

Figure 3.7 SDS-PAGE analysis of induced BL21(DE3) cells harboring pD12. A protein ladder is loaded
in lane 1. Odd numbered lanes are induced samples at the various time points following induction with
IPTG. Even numbered lanes are the corresponding uninduced samples.
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75 kD
PhnA1a
50 kD
PhnA4?
32 kD
25 kD
PhnA2a
15 kD

PhnA3?

Figure 3.8 SDS-PAGE analysis of induced BL21(DE3) cells harboring both pD12 and pACD34. Protein
ladder is loaded in lane 1. Samples in odd numbered lanes are induced and the corresponding uninduced
samples are loaded in the even numbered lanes. Two prominent bands can be seen for PhnA1a and
PhnA2a. No appropriately sized bands are present for PhnA3 and PhnA4.

Since no bands indicated the expression of the two ferredoxin subunits, pACD3 and
pACD34 were introduced into the expression host to check expression levels in the
absence of pD12. When BL21(DE3)(pACD3) cells carrying the plasmid with the phnA3
gene only was induced for expression, a band of about 15 kD representing the cloned
phnA3 gene product was detected by SDS-PAGE. When BL21(DE3)(pACD34) carrying
both phnA3 and phnA4 was induced, a 15 kD band indicative of the phnA3 product was
again seen. However, it was present in a lower concentration than when this gene was
expressed alone. Additionally, there was a band below the 50 kD mark. This was
presumed to be the 45 kD product of phnA4 (Fig. 3.9).
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pACD3
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Figure 3.9 SDS-PAGE analysis of BL21(DE3) cells harboring only pACD3 (samples on the left) to
express phnA3 only, and pACD34 (samples on the right) expressing phnA3 and phnA4. A protein ladder is
loaded in lane 1. Uninduced samples are in lanes 2,4, 7 and 9. Induced samples are in lanes 3,5,8 and 10.

3.5 Assay for Recombinant Protein Activity
To test the enzyme activity of the recombinant proteins, all four dioxygenase
components were expressed by inducing BL21(DE3)(pD12)(pACD34) with IPTG. The
induced cells were then incubated with either naphthalene, phenanthrene, or fluoranthene.
The results of the recombinant protein activity assay are summarized in Table 3.2.
When grown in the presence of naphthalene, a product was detected through GC-MS
with a retention time of 15.73 minutes (Fig. 3.10). The EI mass spectrum (molecular ion
at m/z 306) of this product was similar to the mass spectrum found previously for a
trimethylsilylated naphthalene dihydrodiol production (45) (Fig. 3.11). In addition, no
dihydrodiol product was found in the control.
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When incubated with phenanthrene, GC-MS also detected a product indicating
biotransformation of phenanthrene by the dioxygenase with a retention time of 21.67
minutes (Fig. 3.12). This product was identified as a phenanthrene dihydrodiol since it
had the same fragmentation pattern (molecular ion at m/z 356) as the trimethylsilylated
phenanthrene dihydrodiol previously described (45) (Fig. 3.13).
When cells expressing all four components of the dioxygenase were incubated with
fluoranthene, no breakdown products were detected. However, unlike with naphthalene
and phenanthrene, after several hours of incubation, fluoranthene was still detected in the
supernatant of all cultures including the controls. This might indicate a problem with
uptake of fluoranthene.
A second assay for fluoranthene was carried out using the cell lysate. Cells expressing
all four proteins were induced overnight, harvested, resuspended in Tris buffer (pH 7.5)
and lysed. Fluoranthene was then added to the cell lysate. GC-MS did not detect any
fluoranthene dihydrodiol products in the lysate samples.
The activity of BL21(DE3)(pD12) expressing only the PhnA1a and PhnA2a
oxygenase components was also tested. When these cells were incubated with
naphthalene, phenanthrene, and fluoranthene, no breakdown products were detected by
GC-MS. No fragments were detected to indicate the presence of dihydrodiols for any of
the substrates tested.
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Table 3.2 Summarized results of the recombinant protein activity assay for
BL21(DE3)(pD12)(pACD34) induced cells expressing all four subunits of the
multi-component dioxygnease.
Expressed

Product

RT

Identified

(min)

------

15.73

Compound
Proteins
Control

Naphthalene

A1aA2aA3A4

Naphthalene

Ionization fragments

Naphthalene

73, 147, 191, 203, 275,
15.73

dihydrodiol

Control

Phenanthrene

A1aA2aA3A4

Phenanthrene

-----

-------

306

21.67

Phenanthrene

----73, 147, 165,178, 251,

21.67
dihydrodiol

266, 309, 325, 341, 356

Control

Fluoranthene

--------

----

-----

A1aA2aA3A4

Fluoranthene

--------

----

-----
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Abundance
TIC: 3001002.D\data.ms
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Figure 3.10 Extracted ion chromatograms of BL21(DE3)(pD12)(pACD34) and control cultures incubated
with naphthalene. (A) A breakdown product was identified with a retention time of 15.73 minutes in cells
expressing genes for all dioxygenase components. (B) No compound was identified in the control at the
same retention time. Mass spec data confirmed the compound as a naphthalene dihydrodiol (see Fig 3.11).
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A

Kim et al., (2005)

Abundance
Scan 2189 (15.729 min): 3001002.D\data.ms

B

73.0
110000
100000
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80000
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40000
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10000
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Figure 3.11 (A) EI mass spectrum of naphthalene dihydrodiol as described by Kim et al., (2005).
(B) EI mass spectrum of compound identified at 15.73 minutes in BL21(DE3)(pD12)(pACD34) culture
incubated with naphthalene. Similar fragmentation patterns positively identified this compound as a
naphthalene dihydrodiol.
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Figure 3.12 Extracted ion chromatograms of cultures incubated with phenanthrene. (A) A compound
identified at 21.67 minutes in cells expressing all four genes. (B) No compound was identified in the
control at the same retention time.
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A

Kim et al., 2005.

B
Abundance
Scan 3219 (21.678 min): 3401006.D\data.ms
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Figure 3.13 (A) EI mass spectrum of phenanthrene dihydrodiol (Kim et al., 2005). (B) EI mass spectrum
of the compound identified in BL21(DE3)(pD12)(pACD34) phenanthrene culture with a retention time of
21.67 minutes. The similar fragmentation pattern confirms this compound as a phenanthrene dihydrodiol.

46

atgagcggcgacaccacactcgtagacactgtcaatgctagccagtcccgtcaggtgttc
M S G D T T L V D T V N A S Q S R Q V F
tgggacagagacgtttatgatcttgaaatagagcggattttttcccgggcatggttgatg
W D R D V Y D L E I E R I F S R A W L M
ctcggccacaaatcgcttctcccgaagccgggcgacttcatcacgacttatatggccgag
L G H K S L L P K P G D F I T T Y M A E
gacaagatcatcctttcgcaccagagcgacgggaccttccgcgcctttatcaattcgtgc
D K I I L S H Q S D G T F R A F I N S C
acgcaccgcggcaaccagatttgccacgccgacagcggtaacgccaaggcgttcgtctgc
T H R G N Q I C H A D S G N A K A F V C
aattatcacggctgggtgtacgggcaggatggatcgttggtcgatgtcccactcgagtcg
N Y H G W V Y G Q D G S L V D V P L E S
cgctgttaccacaacaaactcgataagcaagagctggcggcgaagtctgttcgggtcgaa
R C Y H N K L D K Q E L A A K S V R V E
acctacaagggtttcattttcggttgccatgatcccgaagcgccaagccttgaagactac
T Y K G F I F G C H D P E A P S L E D Y
ctgggcgaattccgtttttatctcgacaccatctgggaaggagggggcgctgggctggaa
L G E F R F Y L D T I W E G G G A G L E
ctgctcggtccgccgatgaagagcctgcttcactgcaactggaaagtgccggtcgaaaat
L L G P P M K S L L H C N W K V P V E N
tttgtcggcgacggatatcatgtcggatggacccatgcggcggcgcttggtcagatcggt
F V G D G Y H V G W T H A A A L G Q I G
ggtctgtttgcgggactggccggcaaccgcgcggacattcccttcgacgatcttggattg
G L F A G L A G N R A D I P F D D L G L
cagttcacgacccggcatggtcatggctttgggttggtcgacaacgcggcggctgcgatc
Q F T T R H G H G F G L V D N A A A A I
caccgaaagggcgacggctggaacaaatatcttgaggacacccgcggcgaggtgcgccgc
H R K G D G W N K Y L E D T R G E V R R
aagtttggcgcggatcgcgaacggctttatgtcgggcactggaacggcgcgatcttcccc
K F G A D R E R L Y V G H W N G A I F P
aattgctcgttcctgtatggcaccaacaccttcaaaatctggcatccacgcgggccgcac
N C S F L Y G T N T F K I W H P R G P H
gagattgaagtatggacctataccatggtgccgagcgatgccgatcccgctaccaagagt
E I E V W T Y T M V P S D A D P A T K S
gcgatacagcgcgaagcgacgagaacattcggaaccgccgggacgctggaaagcgacgac
A I Q R E A T R T F G T A G T L E S D D
ggcgaaaacatgtcttcggcaacctacgtgaaccgtggcgtgatcacgcgtgacggcatg
G E N M S S A T Y V N R G V I T R D G M
atgaattcgaccatgggcgtcggctacgaaggaccgcatccggtttatcccggaatcgtc
M N S T M G V G Y E G P H P V Y P G I V
ggcatcagcttcattggcgagacatcctaccggggcttctaccggttctggaaggaaatg
G I S F I G E T S Y R G F Y R F W K E M
atcgatgcccccgattgggcgagcgtgaaggcaaacgacgacaattgggattcggtcttc
I D A P D W A S V K A N D D N W D S V F
acgaatcgcaatttctggaacgaaaagctcaacgcggccgaatga
T N R N F W N E K L N A A E -

Fig. 3.14 Complete phnA1a nucleotide and amino acid sequence

47

atgtcgaccgaacaagttccggtgacgccggatgtgcactacgccgtcgaagcgcactat
M S T E Q V P V T P D V H Y A V E A H Y
cgtgccgaggtcagactgttgcagaccgggcagtaccgggaatggctgcacggaatggtc
R A E V R L L Q T G Q Y R E W L H G M V
gccgaagacatccattactggatgccgatttacgaacagcgcttcgtgagagaccggcgc
A E D I H Y W M P I Y E Q R F V R D R R
ccggacccaacgccagacgatgcggcaatttacaacgacgacttcgaagagctcaagcag
P D P T P D D A A I Y N D D F E E L K Q
cgtgtcgaacggctttattcaggtcaggtctggatggaggatccgccatccaaaatccgg
R V E R L Y S G Q V W M E D P P S K I R
tacttcgtgtcgaatgtcgaagcctttgaagccgaaaacggcgaattggacgtcctgtcg
Y F V S N V E A F E A E N G E L D V L S
aacatccttgtctaccgcaaccgccgccagactgaagtcacggtgcatacattggggcgt
N I L V Y R N R R Q T E V T V H T L G R
gaagacaagttgcgccaggacggcaatggtttcaaggtcttccggcgaaaacttatcctc
E D K L R Q D G N G F K V F R R K L I L
gatgcgagagtcacgcaagacaagaatctgtatttcttttgttag
D A R V T Q D K N L Y F F C -

Fig. 3.15 Complete phnA2a nucleotide and amino acid sequence

atgtcgaacaaactgcgcctttgccaagtagcggacgttaaggatggtgaacctgtcgcg
M S N K L R L C Q V A D V K D G E P V A
gtttaccaggagcaaatgcctgcgcttgccgtctacaacgtcgatggcgatgtattcgtc
V Y Q E Q M P A L A V Y N V D G D V F V
accgacaatatgtgcacccatggcaatgccatgctgaccgatggctaccaggacggcgga
T D N M C T H G N A M L T D G Y Q D G G
atcatcgaatgcccgttccatggtggttccttcgacatcgccaccggagcagccaaagcc
I I E C P F H G G S F D I A T G A A K A
tttccctgccaggttccgatcaagacctactcagtcacgatcgacgacggctgggtgtgc
F P C Q V P I K T Y S V T I D D G W V C
atcgatcagccggaagggagcgcctga
I D Q P E G S A -

Fig. 3.16 Complete phnA3 nucleotide and amino acid sequence
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gtgcgctcgattgctatagttggtgcaaacctggccggtgggcgcgcagtcgaagccctg
V R S I A I V G A N L A G G R A V E A L
cggcaggcagggttcgacgggcggatcaccttgatcggcgaagaaccgtggcgtccttat
R Q A G F D G R I T L I G E E P W R P Y
gaacggccgccgctctccaaggaagtgctgtgggaaccggcaaatgttccggacaatttc
E R P P L S K E V L W E P A N V P D N F
ttcctgcaggacgaggcctggtacgacgataaccgtatcgacatgcgcctgggcacccga
F L Q D E A W Y D D N R I D M R L G T R
gccgaagcaatcgaccttgcgagcggcggggtccgcctgtcagggggcgagctggttcag
A E A I D L A S G G V R L S G G E L V Q
gcggaccggatcctgctcgccacgggcggtcacgcccgcaagctcaaccttgccggggcc
A D R I L L A T G G H A R K L N L A G A
gattgcgagaacgtccattatctgcgcacacgagacgatgcgacccgcatggcgctcgac
D C E N V H Y L R T R D D A T R M A L D
ctgcgcgaaggtgccagcatcgtgatcgtcggcatgggcgtaatcggcgccgaagtcgcc
L R E G A S I V I V G M G V I G A E V A
gccagtgcggtaaaactcggctgcaaggtcaccgtcgtcgagccgatgccagtgccgatg
A S A V K L G C K V T V V E P M P V P M
gaaagagcgctcggccggcgctttgggcaatggctgggcgaggagcatcgcaggcgggga
E R A L G R R F G Q W L G E E H R R R G
gtagcgacccatttcaactgcggcgtgaccggcttcaggtttgccggcaaccgtgtcagc
V A T H F N C G V T G F R F A G N R V S
gcggtcgtggcagacgatggcaccgtgattccgtgcgatgccgtgatcgtgggggtgggg
A V V A D D G T V I P C D A V I V G V G
atcgtgccggccacctcgctggcccgcgatgccgggatcgaggtcaacaacgggatcatc
I V P A T S L A R D A G I E V N N G I I
gtcgaccgtcgatgccagaccagcaacccggcggtattcgcggcgggcgacgtggccgag
V D R R C Q T S N P A V F A A G D V A E
caggacgggtttttcggcggacggttcaggcaggaaacctaccagaacgctgccgaccag
Q D G F F G G R F R Q E T Y Q N A A D Q
gcgcaggcgggcgccctggcgatgctggggcaggaggtctcctactgcaagccgatgtgg
A Q A G A L A M L G Q E V S Y C K P M W
tactggagcgatcagttcgatctcaacatccagttctgcgggcaaattcccgtagaagcc
Y W S D Q F D L N I Q F C G Q I P V E A
gatatcgcaattcgcggcgagatggacagcaacaccttcgtcgccttcttcctggccggt
D I A I R G E M D S N T F V A F F L A G
gaaacgatcgaaggcgtactgacggtcaaccgcgcgcccgacatgggggtgggcaagcgg
E T I E G V L T V N R A P D M G V G K R
ctcgtcgaaaggcgagcccgcgccagcgccgcaagcctggcagacgccaatgtttccttg
L V E R R A R A S A A S L A D A N V S L
cgggacttgctcaagcaggcgggctga
R D L L K Q A G -

Fig 3.17 Complete phnA4 nucleotide and corresponding amino acid sequence. Unlike the other subunits,
PhnA4 starts with a valine.
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Table 3.1 Significant BLAST search results of contigs assembled after sequencing shotgun clones.
Contig #
#1
1-756bp
805-1518bp
#3
1465-2193bp
#4
1-405bp
416-970bp
#5
310-1014bp
#6
4-1035bp
#7
320-1288bp
#8
3-407bp
469-1152bp
#9
2-862bp
1062-1538bp
1591-2190bp
#10
71-1324bp
#11
1-1035bp
#12
1079-2444bp
2488-3013bp
3059-3083bp
#13
2-550bp
550-1044bp
1114-2115bp
2614-3618bp
#14
219-865bp
1154-2054bp
2104-2430bp
2431-2919bp
2942-3742bp
#15
2667-4349bp

Database match

Organism

% Identity

Accession no.

Tni-B like transposition protein
hypothetical protein pCAR_219

Sphingomonas sp. KA1
Sphingomonas sp. KA1

65%
35%

YP 718159.1
YP 718160.1

plasmid stabilization protein

Sphingomonas sp. KA1

82%

YP 718143.1

hydroxythreonine-4-phosphate dehydrogenase
toluene/benzoate dioxygenase small subunit

Sphingobium yanoikuyae
Sphingomonas sp. DN1

91%
89%

ABM79787.1
ACV31387.1

putative transposase

Sphingomonas sp. SKA58

55%

ZP 01301940.1

transposase Tn3 family protein

Ochrobactrum anthropi

73%

YP
001373193.1

2-hydroxy-benzylpyruvate aldolase

Sphingomonas sp. P2

90%

hypothetical protein pCAR_211
putative methylase/helicase

Sphingomonas sp. KA1
Sphingomonas sp. KA1

92%
92%

large subunit of oxygenase
salicylate 1-hydroxylase beta subunit
chain A, Sphingomonad Glutathione Stransferase
putative partitioning protein ParA

Sphingomonas sp. P2
Sphingobium yanoikuyae
Sphingomonads

92%
94%
77%

Sphingomonas sp. KA1

99%

3-isopropylmalate dehydrogenase

Novosphingobium
aromaticivorans
Sphingomonas sp. CHY-1

82%

Sphingomonas sp. CHY-1

100%

Sphingomonas sp. CHY-1

100%

large subunit oxygenase
small subunit oxygenase
amidohydrolase 2
demethylmenaquinone methyltransferase
protein

Sphingomonas sp. P2
Sphingomonas sp. P2
Burkholderia sp. H160
Ralstonia solanacearum
MolK2

96%
93%
45%
40%

putative large subunit toluene/benzoate
dioxygenase, xylX
putative biphenyl-2,3-diol 1,2-dioxygenase,
bphC
putative ferredoxin component of dioxygenase,
bphA3
putative small subunit of oxygenase, ahdA2c
partial putative large subunit of oxygenase,
ahdA1c

Sphingomonaspaucimobilis

99%

FM882255.1

Spingomonas paucimobilis

99%

FM882255.1

Spingomonas paucimobilis

99%

FM882255.1

Spingomonas paucimobilis
Spingomonas paucimobilis

99%
99%

FM882255.1
FM882255.1

putative cation efflux system protein

Pseudomonas aeruginosa

69%

YP790640.1

BAC65452.1

alpha subunit, ring-hydroxylating dioxygenase,
phnA1a
beta subunit, ring-hydroxylating dioxgenase,
phnA2a
partial aryl alchohol dehydrogenase, phnB
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100%

YP 718152.1
YP 718151.1
BAC65433.1
ABM79789.1
1F2E_A
YP 718154.1
NP 049056.1
AJ63551.1
AJ63551.1
AJ63551.1
BAC65453.1
BAC65454.1
ZP 03266800.1
CAQ37090.1

99

AAF72976 Commomonas testosterone

100

AAD12610.1 Ralstonia U2

65

AAB09766 Burkholderia sp. RASC

96

AAD09872 Burkholderia sp.RP007

94

BAD34447 Sphingomonas A4
AAK62353 Burkholderia DBT1
ACG70971 Acidovorax NA3

100

BAC81541 Cycloclasticus A5
ABW37061 Sphingomonas LH128

100

BAB55875 Porphyrobacter sanguineus

100

ABM91740 Sphingomonas yanoikuyae B1

93

Sphingomonas paucimobilis EPA505

100
100

CAG17576 Sphingomonas CHY-1
BAG80733 Rhodococcus sp.YK2
BAA25623.1 Rhodococcus erythropolis

100
100
80

AAB07750 Rhodococcus sp. M5
CAA56346 Rhodococcus globerulus
AAX45786 Pseudomonas putida

100

AAC43632 Pseudomonas sp.

100
99

AAC46390 Burkholderia sp.TecA1

0.1

Fig 3.18 Phylogenetic tree showing the relationship of the alpha subunit PhnA1a and related alpha subunits
of various organisms. Tree was constructed with MEGA version 4.0.
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63
98
100

YP 001268195.1 Pseudomonas putida F1
CAA06971.1 Ralstonia sp. JS705
AAC46391.1 Burkholderia sp.
NP 898769.1 Rhodococcus erythropolis

99

1WQL Pseudomonas Fluorescens

39

YP 003358095.1 Burkholderia cepacia

92
36

YP 001705092.1 Mycobacterium abscessus
59

BAC06603.1 Terrabacter YK3
BAB55887.1 Terrabacter DBF63

43

YP 286445.1 Dechloromonas aromatica

92

BAC65447.1 Sphingomonas sp. P2
AAQ91915.1 Mycobacterium vanbaalenii ...

29

AAR05115.1 Rhodococcus P200

90

BAC81542.1 Cycloclasticus A5
100 NP 049061.1 Novosphingobium aromatici...
99

ABW37062.1 Sphingomonas LH128
2GBW Sphingomonas yanoikuyae B1

100
100

Sphingomonas paucimobilis EPA505

77 2CKF Sphingomonas Chy-1

AAK62354.1 Burkholderia DBT1
BAE93950.1 Sphingomonas A4

99

0.1

Fig. 3.19 Phylogenetic tree showing the relationship of the beta subunit PhnA2a to other known terminal
oxygenase small subunits. Tree was constructed using MEGA 4.0.
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EPA505
CHY-1
S.y B1
S.LH128
C.A5
S.A4
P.NDO

MSGDTTLVDTVNASQSRQVFW-DRDVYDLEIERIFSRAWLMLGHKSLLPKPGDFITTYMA
MSGDTTLVDTVNASQSRQVFW-DRDVYDLEIERIFSRAWLMLGHKSLLPKPGDFITTYMA
MSSDATLVDTVNASQSRQVFW-DEDVYALEIERIFSRAWLMLGHESLVPKPGDFITTYMA
MNGSSALVDNAGASQSRRVFW-DQDVYQLELERIFSRCWLMLGHDSLVPKPGDFITTYMA
MVDINKLVDTKASTQSKEVFW-DQEVYDREIKNIFGRSWLFLTHECMLEKKGDFITTKMA
---MDDLIDTKRGLQSASMFI-DPHLYEVEMEKIFGRCWLFLTHESAIPNYGDFVTAKMG
MNYNNKILVSESGLSQKHLIHGDEELFQHELKTIFARNWLFLTHDSLIPAPGDYVTAKMG
:: . . .. :: * .:: *:: **.* **:* *.. :
**::*: *.

59
59
59
59
59
56
60

EPA505 EDKIILSHQSDGTFRAFINSCTHRGNQICHADSGNAKAFVCNYHGWVYGQDGSLVDVPLE
CHY-1 EDKIILSHQSDGTFRAFINSCTHRGNQICHADSGNAKAFVCNYHGWVYGQDGSLVDVPLE
S.y B1 EDKVILSHQSDGTFRAFINSCSHRGNQICHADSGNAKAFVCNYHGWVFGQDGSLVDVPLE
S.LH128EDRVILSRQPDGSLKAFINSCTHRGNQICHADSGSAKAFVCNYHGWVFGQDGSLVDVPME
C.A5
EDSVIVTRHTDGSLKAFVNSCTHRGNSICSADSGNTKSFVCNYHGWVFSTDGKLVDVPLR
S.A4
EDEVLVVRQEDGTVKAFLNVCRHRGARVCPVEAGNRRAFVCNYHGWSYAADGSLAAIPFE
P.NDO IDEVIVSRQNDGSIRAFLNVCRHRGKTLVSVEAGNAKGFVCSYHGWGFGSNGELQSVPFE
* ::: :: **:.:**:* * *** : .::*. :.***.**** :. :*.* :*:.

119
119
119
119
119
116
120

EPA505 SRCYHNKLDKQELAAKSVR-VETYKGFIFGCHDPEAPSLEDYLGEFRFYLDTIWEGGGAG
CHY-1 SRCYHNKLDKQELAAKSVR-VETYKGFIFGCHDPEAPSLEDYLGEFRFYLDTIWEGGGAG
S.y B1 SRCYHNSLDKQKLAAKSVR-VETYKGFIFGCHDPEAPSLEDYLGEFRYYLDTIWEGAGGG
S.LH128ERCYHSDLDKSKLGLAPIR-VETYKGFIFGCHDPEAPSLEDYLGDFCWYLDTIWDGPDGG
C.A5
EKCYHDELDRDSLSLKTIR-VESYRGFVFGCFDETAPSLEDFLGDWGWYLDTWMVGAGEG
KELYGGKIDRCAHGLKEVAKVDSYRGFLFGNFDPGAISLEDYLGDVRWYLDIWMEASG-G
S.A4
P.NDO KDLYGESLNKKCLGLKEVARVESFHGFIYGCFDQEAPPLMDYLGDAAWYLEPMFKHSG-G
. * .:::
.
: *::::**::* .* * .* *:**: :**:
. *

178
178
178
178
178
175
179

EPA505 LELLGPPMKSLLHCNWKVPVENFVGDGYHVGWTHAAALGQIGGLFAGLAGNRADIPFDDL
CHY-1 LELLGPPMKSLLHCNWKVPVENFVGDGYHVGWTHAAALGQIGGPLAGLAGNRADIPFDDL
S.y B1 MELLGPPMKSLLQCNWKVPAENFIGDGYHVGWTHAAALSQIGGELAGLAGNRADIPFDDL
S.LH128LELVGPPLKSTLACNWKVPTENFVGDGYHVGWTHAAALQMIGGELAGLSGNRADMPFDDL
C.A5
AELVGPPMKSILKCNWKVPTENFVGDGYHVGWTHASALHVLGGELGGLAGNQAEMPFDEL
S.A4
VELIGPPARSIVHCNWKAPTENFVGDAYHIGWTHASSLAASRSIFAPMSGN-QMLPPAGA
P.NDO LELVGPPGKVVIKANWKAPAENFVGDAYHVGWTHASSLRSGESIFSSLAGN-AALPPEGA
**:*** : : .***.*.***:**.**:*****::*
. :. ::**
:*

238
238
238
238
238
234
238

EPA505 GLQFTTRHGHGFGLVDNAAAAIHRKG--DGWNKYLEDTRGEVRRKFGADRERLYVGHWNG
CHY-1 GLQFTTRHGHGFGVIDNAAAAIHRKG--DGWNKYLEDTRGEVRRKFGADRERLYVGHWNG
S.y B1 GLQFTTRHGHGFGVIDNAAAGLHIKR--EGWTKFLEDTRGEVRRKFGPERERLYLGHWNC
S.LH128GLQFTMRHGHGFGLIDNAATAIHVKR--DGYVKYLEQTRGGIREKFGPERERLYVGHWNT
C.A5
GIQVTTRHGHGFGVIDNAAIAIHAKR--DEYAKYMEETIPKVAENLGEPRAKLFNGHWNC
S.A4
GAQIATRFGHGLGILYDVNPGVHTAQTAEKILAWQATKKDKIAEKYGELKARFYGSHLNG
P.NDO GLQMTSKYGSGMGVLWDGYSGVHSADLVPELMAFGGAKQERLNKEIGDVRARIYRSHLNC
* *.: :.* *:*:: :
.:*
:
.
: .: * : ::: .* *

296
296
296
296
296
294
298
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Fig 3.20 Multiple sequence alignment of PhnA1a (alpha subunit of the terminal oxygenase component)
with the alpha subunits of Sphingomonas sp. CHY-1 (CHY-1), Sphingobium yanoikuyae B1 (S. y B1),
Sphingomonas sp. LH128 (S.LH128), Cycloclasticus sp. A4, Sphingomonas sp. A4, and the naphthalene
dioxygenase alpha subunit of Pseudomonas . Fully conserved amino acid residues are indicated by an
asterisk. Five conserved histidines and two conserved cysteines are highlighted in yellow. The conserved
Asp205 is highlighted in gray. Regions highlighted in red are hypothesized to be responsible for the ability
to breakdown large substrates (Leu223, Leu226, Ile253 and Ile260 of CHY-1) (52). Alignment was
constructed with ClustalW.
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Fig 3.21 Multiple sequence alignment of PhnA2 (beta subunit of the terminal oxygenase component) with
the beta subunit of Sphingomonas sp. CHY-1 (CHY-1), Sphingobium yanoikuyae B1, Sphingomonas sp.
LH128 (S.LH128), Cycloclasticus sp. A5 (C.A5), Pseudomonas fluorescens(Pseudo), and Sphingomonas
sp. A4 (S.A4). Conserved residues are indicated by asterisks.
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DISCUSSION

Members of the genus Sphingomonas are known for their abilities to breakdown a
wider range of PAH substrates compared to other PAH degrading bacteria (40). Because
of their potential for bioremediation, it is necessary to study these organisms in more
detail to understand the breakdown process at the molecular level. Many enzymes are
involved in the PAH breakdown process. The first enzyme in the pathway is always a
ring-hydroxylating dioxygenase (28). Dioxygenases are of particular importance since
they initiate the pathway by breaking the aromatic ring of the hydrocarbon.
Dioxygenases are multi-component enzymes usually consisting of oxygenase
components and a ferredoxin and/or a ferredoxin reductase (41).
Sphingomonas paucimobilis EPA505 was isolated from a seven member community
at a creosote waste site (34). This organism was able to degrade high molecular weight
PAHs and even demonstrated an ability to use one PAH as a sole carbon source. After
constructing a BAC library, oligonucleotide probes were designed specifically to target
dioxygenase genes. After selecting BAC clones that hybridized to the probe, a shotgun
library was constructed to carry out high throughput sequencing.
Sequencing shotgun clones revealed many putative genes (Table 3.1). From the
sequencing data assembled, S. paucimobilis EPA505 appears to have many different
dioxygenases. This is not surprising as other Sphingomonads have been shown to have
genes encoding more than one dioxygenase.
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Multiple dioxygenase genes were identified and phnA1a, phnA2a, and phnA3 were
chosen for further analysis. These three genes encode three subunits of a dioxygenase.
All together these proteins were expected to form a dioxygenase complex which could
breakdown both high and low molecular weight PAHs. The three genes encode an alpha
and beta oxygenase component, and a ferredoxin component respectively. According to
Demaneche et al. (38), a fourth gene encoding a ferredoxin reductase subunit was also
necessary for optimal activity. However this gene was not identified in the assembled
sequences of this study. Multiple rounds of PCR and sequencing were carried out to
eventually obtain the entire sequence of a gene which was 100% similar to the ahdA4
gene of Spingomonas sp. P2. This gene encodes a ferredoxin reductase and was named
phnA4 for this study.
Phylogenetic analysis of the PhnA1a and PhnA2a subunits showed similarity of these
terminal oxygenase components to many other naphthalene dioxygenase like enzymes in
various organisms (Fig. 3.18 and 3.19). A multiple sequence alignment revealed some
amino acid conservation in the beta subunit, but much more conservation among the
alpha subunits (Fig. 3.20 and 3.21). All alpha subunits aligned showed five conserved
histidine and two conserved cysteine residues which are believed to be critical for protein
function. The Asp205 residue was also conserved among all enzymes. This amino acid
is thought to directly connect the active iron center of one alpha subunit to the
neighboring unit as the main route for electron transfer (58).
All four genes were cloned for expression. BL21(DE3) host cells expressing the
oxygenase components only as well as cells expressing all four components were
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induced. When BL21(DE3)(pD12) cells harboring the plasmid to express PhnA1a and
PhnA2a oxgenase subunits were induced with IPTG, a 53 kD and 21 kD protein was
detected by SDS-PAGE (Fig 3.7). These two bands indicated the successful expression
of the phnA1a and phnA2a genes since they were present only in the induced samples.
When BL21(DE3) cells harboring the plasmids pD12 and pACD34 were induced for
expression, the only bands detected by SDS-PAGE were representative of the phnA1a
and phnA2a genes of pD12 (Fig 3.9). No expression was seen for either ferredoxin
component (phnA3, phnA4) cloned on the pACD34 plasmid. Unsuccessful expression
could be attributed the plasmid copy number. Plasmid pD12 carrying the genes phnA1a
and phnA2a, was derived from pETDuet-1. This vector has an estimated copy number of
40. Plasmid pACD34 carrying the two genes encoding the ferredoxin components,
namely phnA3 and phnA4, was derived from pACYCDuet-1. This vector has an
estimated copy number of 10. Because the latter has a much lower copy number, and
because copy number probably decreases as genes are cloned into the vector, the amount
of expression subsequently decreased. This might explain why expression of the genes
cloned into the vector with the higher copy number was only visible with SDS-PAGE.
Another explanation could be that there was a problem in the construction of the
plasmids for expression. Sequencing was carried out to confirm genes were in frame
after cloning. However, to be sure that the lack of expression was not an issue with the
vector, pACD34 was introduced into BL21(DE3) cells to check for expression in the
absence of pD12. BL21(DE3) cells were also transformed with pACD3 which only
harbored the phnA3 gene. After induction of BL21(DE3)(pACD3), an appropriately
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sized band of 15 kD was observed with SDS-PAGE indicating successful expression of
PhnA3. After inducing BL21(DE3)(pACD34), a 15 kD band and another band below the
50 kD mark were observed. The band below the 50 kD mark was assumed to be the 45
kD ferredoxin reductase component as it was only present in the induced samples. In
addition, the 15 kD size band representing the phnA3 gene product was lower in
concentration compared to when this gene was expressed alone. This was another
indication that both genes were being expressed.
The successful expression of the phnA3 and phnA4 genes in the absence of pD12
confirmed that there was no problem with the expression vector or the construct. The
lack of expression seen was probably due to the low copy number. When cells harboring
both plasmids are induced to express all four subunits, the ferredoxin components were
most likely being expressed. However, expression was at such a low level that these
proteins were not being detected by SDS-PAGE.
Enzyme activity of the recombinant proteins was examined. To look for dioxygenase
activity, BL21(DE3)(pACD34) and BL21(DE3)(pD12) cells were both tested for the
ability to transform PAHs into their corresponding dihydrodiol products.
Demaneche et al. observed enzyme activity, albeit minimal, when the oxygenase
components of Sphingomonas CHY-1 were expressed in the presence of PAHs. When
cells expressing only the PhnA1a and PhnA2a proteins of CHY-1 were incubated with
various PAHs, dihydrodiol products were detected (38). Although the activity was much
lower than the activity observed by cells carrying all four subunits, the two oxygenase
components were able to transform the PAHs without the ferredoxin components. To test
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this for EPA505’s dioxygenase, BL21(DE3)(pD12) cells harboring the plasmid to
express only the PhnA1a and PhnA2a products were grown in the presence of PAHs.
However, unlike experiments with CHY-1, no dihydrodiol product was detected by
GC-MS.
When BL21(DE3)(pD12)(pACD34) was incubated with naphthalene, a product with
the GC-MS characteristics of a naphthalene dihydrodiol was detected. The EI mass
spectrum of this product was compared to the previously described mass spectra of
naphthalene dihydrodiol formed by Mycobacterium vanbaalenii (45). The similarities
between the mass spectra obtained in this study and that of Kim et al. (45) confirmed the
presence of naphthalene dihydrodiol.
When cells expressing the complete dioxygenase were incubated with phenanthrene,
the presence of a phenanthrene dihydrodiol was confirmed by comparing the mass
spectra obtained to that of Kim et al. (45). The fragmentation patterns observed for the
products detected confirm the presence of dihydrodiols. These dihydrodiols are evidence
of dioxygenase activity and show the ability of these recombinant proteins to work
together to transform the PAH substrates into corresponding breakdown products.
BL21(DE3)(pD12)(pACD34) cells expressing all four subunits of the dioxygenase
were able to break down naphthalene and phenanthrene into corresponding dihydrodiols,
whereas cells expressing only the oxygenase components showed no dioxygenase
activity. The difference in activity supports the idea that the ferredoxin components were
being expressed even though they were not detected by SDS-PAGE.
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It appears that in EPA505, all four components are necessary for dioxygenase activity.
However, the enzyme activity is being analyzed with recombinant proteins. This might
have an effect on the stability of the proteins in the cell, as compared to when they are
produced naturally by EPA505. Considering the similarity between the phnA1a and
phnA2a genes of EPA505 and those in Sphingomonas CHY-1, it is difficult to believe
that their protein products do not have some ability to transform PAHs without the
ferredoxin components. It is also possible that some of the other dioxygenases identified
may show PAH degrading activity without the ferredoxin components. Until all factors
are taken into account, and all assay conditions are tested, it cannot be said with certainty
that all four components are absolutely required for activity.
When the enzyme was exposed to the HMW PAH, fluoranthene, no breakdown
products were observed in the whole cell assay or the assay using cell lysate. The lack of
activity with the whole cell assay could be attributed to an inability of the BL21(DE3)
cells to take up the fluoranthene. This host does not secrete overexpressed proteins into
the media. Therefore, the only way for the proteins and the substrate to interact would be
for the substrate to enter the cell. When the whole cell assay was carried out for
naphthalene and phenanthrene, dihydrodiol products were identified. More importantly,
there was little or none of the original substrate in the supernatant of the cells expressing
the enzyme as well as the control cells. The lack of the original substrate, even in the
control cells where no breakdown products were detected, is probably an indication that
the PAH is entering the cell where it can come in contact with the enzyme. With the
fluoranthene experiments, however, no dihydrodiol products were identified and unlike
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the other substrates, fluoranthene remained in the supernatant. Since fluoranthene is a
larger compound than naphthalene and phenanthrene, it is possible that this substrate is
not entering the cell as easily and is not coming in contact with the enzyme. This may be
one reason why fluoranthene was not broken down as expected.
To ensure contact between the enzyme and fluoranthene, another activity assay was
carried out using the cell lysate. Once again, no dihydrodiol products were identified.
However, the lack of activity against fluoranthene does not rule out the ability of this
enzyme to break down HMW PAHs. Even though fluoranthene was not broken down,
this could be due to instability on the part of the enzyme. After induction, cells were
resuspended in a simple Tris buffer and lysed. This lysate was then used to test activity
against fluoranthene. It is possible that the buffering conditions were not optimal and the
recombinant proteins were not stable after cell lysis. If this assay is repeated, the cell
lysate should also be tested against naphthalene and phenanthrene as controls since the
enzyme was shown to degrade these compounds.
There is a possibility that the substrate range of the PhnI protein in EPA505 is just not
the same as other dioxygenases. BLAST similarity search results indicate the terminal
oxygenase components of EPA505 are 99% similar to those of Sphingomonas CHY-1.
However, CHY-1 was shown to have great versatility in breaking down both low and
high molecular weight PAHs. When the crystal structure of the PAH degrading
dioxygenase of CHY-1 was determined by Jakoncic et al. (52), the authors found that the
catalytic pocket of the enzyme from CHY-1 is at least 2Å longer, wider and higher at the
entrance when compared to other ring-hydroxylating dioxygenases. This larger pocket
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was attributed to the amino acids Leu223, Leu226, Ile253, and Ile260. The multiple sequence
alignment indicates that EPA505’s alpha subunit only contains the Leu226 and the Ile260.
This may be a reason why EPA505 was unable to breakdown fluoranthene. Although
PhnA1a of EPA505 shares such high similarity with the PhnA1 of CHY-1, the
differences in these amino acid residues may account for EPA505’s inability to
breakdown larger substrates.
Sphingomonas paucimobilis EPA505 has great potential as a tool for bioremediation.
In this study, a multi-component dioxygenase was identified and tested for activity
against different PAHs. To our knowledge this is the first report of functional analysis of
dioxygenase from EPA505. Future studies will include a more detailed analysis of this
enzyme as well as the other dioxygenases identified. Testing enzyme activity in different
environments in order to find out optimal activity conditions as well as conditions which
inhibit activity may eventually lead to better bioremediation strategies.
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